Nuo TherapeuticsAURX -8.91%33 Days Inventory is 46.74 as of Mar. 2026, which is 42% below its 10-year median of 80.04. GuruFocus rates AURX with a GF Score™ of 33/100 and a GF Value™ of $4.27 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 635 Biotechnology companies, Nuo Therapeutics ranks better than 86.46% on this metric.
The historical rank and industry rank for Nuo Therapeutics's Days Inventory or its related term are showing as below:
AURX'
s Days Inventory Range Over the Past 10 Years
Min: 17.73 Med: 80.04 Max: 4610.53
Current: 47.58
During the past 13 years, Nuo Therapeutics's highest Days Inventory was 4610.53. The lowest was 17.73. And the median was 80.04.
AURX's Days Inventory is ranked better than 86.46% of 635
companies
in the Biotechnology industry
Industry Median: 183.23
vs AURX: 47.58
Nuo Therapeutics's Days Inventory
declined
from Mar. 2025 (93.89) to Mar. 2026 (46.74).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Nuo Therapeutics's Inventory Turnover for the
three
months ended in Mar. 2026 was 1.95.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Nuo Therapeutics's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.18.
Nuo Therapeutics (OTCPK:AURX) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Nuo Therapeutics's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Nuo Therapeutics's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Nuo Therapeutics Days Inventory Related Terms
Nuo Therapeutics Days Inventory Historical Data
* Premium members only.
The historical data trend for Nuo Therapeutics's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AURX vs PDSB, LTRN, VERU: Days Inventory Comparison
For the Biotechnology subindustry, Nuo Therapeutics's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nuo Therapeutics Days Inventory vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Nuo Therapeutics's Days Inventory distribution charts can be found below:
* The bar in red indicates where Nuo Therapeutics's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nuo Therapeutics (AURX) has a Days Inventory of 46.74 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Nuo Therapeutics and its competitors. This is 42% below median its historical median of 80.04. Over the past decade, Nuo Therapeutics' Days Inventory has ranged from 17.73 to 4,610.53. According to the industry distribution chart, Nuo Therapeutics ranks #86 out of 635 companies in the Biotechnology industry, placing it in the top 13.5%.
Is Nuo Therapeutics' Days Inventory too high?
Nuo Therapeutics' current Days Inventory of 46.74 is 42% below median its 10-year median of 80.04. Over the past 10 years, this metric has ranged from a low of 17.73 to a high of 4,610.53. The Biotechnology industry median Days Inventory is 183.23. Nuo Therapeutics' value of 46.74 is 74.5% below this industry median. Based on the distribution chart, Nuo Therapeutics ranks #86 out of 635 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Nuo Therapeutics has a GF Score™ of 33/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Nuo Therapeutics' Days Inventory compare to PDSB and LTRN?
According to the Biotechnology industry distribution chart, Nuo Therapeutics ranks #86 out of 635 companies for Days Inventory. This places Nuo Therapeutics in the top 14% of its industry — outperforming the majority of peers. The industry median Days Inventory is 183.23. Nuo Therapeutics' value of 46.74 is 74.5% below this benchmark. Historically, Nuo Therapeutics' own Days Inventory has ranged from 17.73 to 4,610.53 over the past decade. While the company's 10-year median is 80.04 vs. the industry median of 183.23, Nuo Therapeutics has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 183.23, based on 635 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Nuo Therapeutics's current Days Inventory of 46.74 is 74.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Nuo Therapeutics and its competitors. For the Biotechnology industry, the median Days Inventory is 183.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nuo Therapeutics's current Days Inventory is 46.74, which is 42% below median its own 10-year median of 80.04. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nuo Therapeutics stock overvalued right now?
Based on GuruFocus' analysis, Nuo Therapeutics (AURX) is currently considered Possible Value Trap. The stock's GF Value™ is $4.27, compared to a current price of $0.92 — trading 78.5% below its estimated fair value. The current Days Inventory is 46.74, which is 42% below median its 10-year median of 80.04 and 74.5% below the Biotechnology industry median of 183.23. Nuo Therapeutics' overall GF Score™ is 33/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Nuo Therapeutics (AURX), the current Days Inventory is 46.74 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Nuo Therapeutics (AURX) Overvalued in 2026?
Based on GuruFocus' analysis, Nuo Therapeutics stock appears to be undervalued.
The current stock price of $0.92 is trading 78.5% below its estimated GF Value™ of $4.27.
GuruFocus considers Nuo Therapeutics to be Possible Value Trap.
Key valuation signals for AURX:
Days Inventory: 46.74 (42% below median its 10-year median of 80.04)
GF Value™: $4.27 vs. price of $0.92 (78.5% below fair value)
Industry Position: 74.5% below the Biotechnology median (#86 of 635)
No single metric tells the full story. See the AURX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Nuo Therapeutics Inc is a commercial-stage medical device company engaged in developing and marketing products for chronic wound care. The company operates as a single segment focused on regenerative therapies that utilize autologous (patient-derived) biological materials to promote natural healing. Its primary commercial product is the Aurix System, a point-of-care technology that produces platelet-rich plasma (PRP) therapy from a patient's own blood for use in the treatment of chronic wounds.
33GF Score
Get the complete analysis for AURX
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AURX has been successfully added to your 
